A type III effector antagonizes death receptor signalling during bacterial gut infection

Nature

Volumn 501, Issue 7466, 2013, Pages 247-251

  Pearson, Jaclyn S ^a   Giogha, Cristina ^a   Ong, Sze Ying ^a   Kennedy, Catherine L ^a   Kelly, Michelle ^a   Robinson, Keith S ^b   Lung, Tania Wong Fok ^a   Mansell, Ashley ^c   Riedmaier, Patrice ^a   Oates, Clare V L ^a   Zaid, Ali ^a   Mühlen, Sabrina ^a   Crepin, Valerie F ^b   Marches, Olivier ^d   Ang, Ching Seng ^e   Williamson, Nicholas A ^e   O'Reilly, Lorraine A ^a,f   Bankovacki, Aleksandra ^f   Nachbur, Ueli ^f   Infusini, Giuseppe ^f   Webb, Andrew I ^a,f   Silke, John ^a,f   Strasser, Andreas ^a,f   Frankel, Gad ^b   Hartland, Elizabeth L ^a,g   more..

^a UNIVERSITY OF MELBOURNE   (Australia)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c HUDSON INSTITUTE OF MEDICAL RESEARCH   (Australia)

^d QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^e UNIVERSITY OF MELBOURNE   (Australia)

^f WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^g ROYAL CHILDREN'S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 8; DEATH DOMAIN RECEPTOR SIGNALING ADAPTOR PROTEIN; DEATH RECEPTOR; FAS ASSOCIATED DEATH DOMAIN PROTEIN; FAS LIGAND; GLYCOGENIN; GLYCOSYLTRANSFERASE; N ACETYLGLUCOSAMINE TRANSFERASE; PHOSPHOTRANSFERASE; PROTEIN NLEB; PROTEIN RIPK1; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED DEATH DOMAIN PROTEIN; UNCLASSIFIED DRUG;

ANTIMICROBIAL ACTIVITY; APOPTOSIS; BACTERIUM; COLONIZATION; ENZYME ACTIVITY; INFECTIVITY; INHIBITION; PROTEIN; RODENT; SIGNALING; VIRULENCE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BACTERIAL VIRULENCE; CITROBACTER RODENTIUM; CONTROLLED STUDY; ENTEROPATHOGENIC ESCHERICHIA COLI; ENZYME ACTIVATION; ENZYME ACTIVITY; HOST CELL; HOST RESISTANCE; IMMUNE RESPONSE; INTESTINE INFECTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN INTERACTION; SIGNAL TRANSDUCTION; TYPE III SECRETION SYSTEM;

ANIMALS; ANTIGENS, CD95; CASPASE 8; CELL DEATH; CITROBACTER RODENTIUM; ENTEROPATHOGENIC ESCHERICHIA COLI; ENZYME ACTIVATION; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI PROTEINS; FAS LIGAND PROTEIN; FAS-ASSOCIATED DEATH DOMAIN PROTEIN; FEMALE; GASTROINTESTINAL TRACT; HEK293 CELLS; HELA CELLS; HUMANS; MALE; MICE; N-ACETYLGLUCOSAMINYLTRANSFERASES; PROTEIN STRUCTURE, TERTIARY; RECEPTOR-INTERACTING PROTEIN SERINE-THREONINE KINASES; SIGNAL TRANSDUCTION; TNF RECEPTOR-ASSOCIATED DEATH DOMAIN PROTEIN; VIRULENCE FACTORS;

EID: 84884137769     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature12524     Document Type: Article

References (24)

1. Wong, A. R. et al. Enteropathogenic and enterohaemorrhagic Escherichia coli: even more subversive elements. Mol. Microbiol. 80, 1420-1438 (2011).
2. Srikanth, C. V., Mercado-Lubo, R., Hallstrom, K. & McCormick, B. A. Salmonella effector proteins and host-cell responses. Cell. Mol. Life Sci. 68, 3687-3697 (2011).
3. Ashida, H. et al. Shigella deploy multiple countermeasures against host innate immune responses. Curr. Opin. Microbiol. 14, 16-23 (2011).
4. Park, H. H. et al. The death domain superfamily in intracellular signaling of apoptosis and inflammation. Annu. Rev. Immunol. 25, 561-586 (2007).
5. Strasser, A., Jost, P. J. & Nagata, S. The many roles of FAS receptor signaling in the immune system. Immunity 30, 180-192 (2009).
6. Schneider-Brachert, W. et al. Compartmentalization of TNF receptor 1 signaling: internalizedTNF receptosomes asdeath signaling vesicles. Immunity21, 415-428 (2004).
7. Micheau, O. & Tschopp, J. Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes. Cell 114, 181-190 (2003).
8. Newton, H. J. et al. The type III effectors NleE and NleB from enteropathogenic E. coli and OspZfromShigella block nuclear translocationofNF- kBp65. PLoS Pathog. 6, e1000898 (2010).
9. Zhang, L. et al. Cysteine methylation disrupts ubiquitin-chain sensing in NF-kB activation. Nature 481, 204-208 (2012).
10. Gao, X. et al. NleB, a bacterial effector with glycosyltransferase activity, targets GAPDH function to inhibit NF-kB activation. Cell Host Microbe 13, 87-99 (2013).
11. Imtiyaz, H. Z., Zhang, Y. & Zhang, J. Structural requirements for signal-induced target binding of FADD determined by functional reconstitution of FADD deficiency. J. Biol. Chem. 280, 31360-31367 (2005).
12. Wang, L. et al. The Fas-FADD death domain complex structure reveals the basis of DISC assembly and disease mutations. Nature Struct. Mol. Biol. 17, 1324-1329 (2010).
13. Strasser, A., Harris, A. W., Huang, D. C., Krammer, P. H. & Cory, S. Bcl-2 and Fas/APO-1 regulate distinct pathways to lymphocyte apoptosis. EMBO J. 14, 6136-6147 (1995).
14. Kelly, M. et al. Essential role of the type III secretion system effector NleB in colonization of mice by Citrobacter rodentium. Infect. Immun. 74, 2328-2337 (2006).
15. Jost, P. J. et al. XIAP discriminates between type I and type II FAS-induced apoptosis. Nature 460, 1035-1039 (2009).
16. Kaufmann, T. et al. The BH3-only protein bid is dispensable for DNA damage- and replicative stress-induced apoptosis or cell-cycle arrest. Cell 129, 423-433 (2007).
17. Mundy, R. et al. Identification of a novel Citrobacter rodentium type III secreted protein, EspI, and roles of this and other secreted proteins in infection. Infect. Immun. 72, 2288-2302 (2004).
18. Deng, W. et al. Dissecting virulence: systematic and functional analyses of a pathogenicity island. Proc. Natl Acad. Sci. USA 101, 3597-3602 (2004).
19. Wickham, M. E., Brown, N. F., Boyle, E. C., Coombes, B. K.& Finlay, B. B. Virulence is positively selected by transmission success betweenmammalian hosts. Curr. Biol. 17, 783-788 (2007).
20. Wickham, M. E. et al. Bacterial genetic determinants of non-O157 STEC outbreaks and hemolytic-uremic syndrome after infection. J. Infect. Dis. 194, 819-827 (2006).
21. Karmali, M.A. et al. Association of genomicOisland122 of Escherichia coliEDL 933 with verocytotoxin-producing Escherichia coli seropathotypes that are linked to epidemic and/or serious disease. J. Clin. Microbiol. 41, 4930-4940 (2003).
22. Jostins, L. et al. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 491, 119-124 (2012).
23. Datsenko, K. A. & Wanner, B. L. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc. Natl Acad. Sci. USA 97, 6640-6645 (2000).
24. Isono, T. O-GlcNAc-specific antibody CTD110.6 cross-reacts with N-GlcNAc2- modified proteins induced under glucose deprivation. PLoS ONE 6, e18959 (2011).